In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...

Before Congress adjourned for Christmas, congressional leadership had set ambitious goals to counter the Chinese Communist ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.

Chinese cybersecurity regulator details on the lenient certification method for cross-border data transfer; U.S. issues final ...

WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...

The transaction – announced on Christmas Eve – comes after WuXi AppTec has been thrust into the US political spotlight as a ...

The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s ...

A summary of recent health news includes Louisiana's first bird flu death, WuXi Biologics' sale of an Irish facility to Merck ...

Wuxi Biologics (WXXWY) plans to sell its Irish vaccine facility to Merck (MRK) for around $500M ahead of potential U.S. legislation that would ...

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show ...